Notice of 29th EGM and Proposed Amendment to Articles of Incorporation

Kyungnam Pharm will hold an EGM on May 26, 2026, to vote on amending the articles of incorporation (adding business purposes).
FY2025 financials: Sales 55.9 billion KRW (YoY -8%), operating loss 1.73 billion KRW (loss widened), net loss 9.0 billion KRW (swing to loss).
Key amendment: Add pet supplies wholesale/retail/manufacturing, feed, and alcohol import/export/distribution (business diversification).
Outside director compensation: AGM-approved limit of 30 million KRW for 2 directors, total paid 170,000 KRW (average 40,000 KRW per person).
Board activity: 10 meetings held Jan-May 2026, outside director changes (resignation and new appointment on Mar 26).
Physical certificate holders must convert to electronic registration due to electronic securities system.